Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:14 PM
Ignite Modification Date:
2025-12-24 @ 4:14 PM
NCT ID:
NCT01627366
Eligibility Criteria:
Inclusion Criteria:
* Female
* 21 years of age or older
* English- or Spanish-speaking
* Diagnosis of ductal carcinoma in situ (DCIS) or Stage I, II, or III BC for the first time
* 10-24 months post-diagnosis
* At least 1 month post-chemotherapy completion
Exclusion Criteria:
* Previous cancer except non-melanomatous skin cancers or in situ non-breast cancers
* Pregnant and lactating women
* Patients receiving parenteral anti-cancer therapy, except trastuzumab
* Clinically apparent cognitive or psychiatric impairment
* Participation in another research study
* Current treatment for another cancer
* Male
* Residing outside of Los Angeles County
* Too ill to participate
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
21 Years
Study:
NCT01627366
Study Brief:
Protocol Section:
NCT01627366